Screening for genes associated with ovarian cancer prognosis

Chinese Medical Journal

Volumn 122, Issue 10, 2009, Pages 1167-1172

  Chang, Xiao Hong ^a   Zhang, Li ^b   Yang, Rong ^a   Feng, Jie ^a   Cheng, Ye Xia ^a   Cheng, Hong Yan ^a   Ye, Xue ^a   Fu, Tian Yun ^a   Cui, Heng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b Department of Obstetrics   (China)

Author keywords

Cell receptor; Immunity associated; Microarray; Ovarian cancer; Prognosis

Indexed keywords

BETA 2 MICROGLOBULIN; CELL RECEPTOR; FIBRONECTIN; FIBRONECTIN 1; PERICENTRIOLAR MATERIAL 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING PROTEIN; POLO LIKE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN GENOME; HUMAN TISSUE; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; NUCLEOTIDE SEQUENCE; OVARY CANCER; PROGNOSIS;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION;

EID: 68249153237     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.10.010     Document Type: Article

References (20)

1. Crijns AP, Duiker EW, de Jong S, Willemse PH, van der Zee AG, de Vries EG. Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy. Int J Gynecol Cancer 2006; 16: 152-165.
2. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-470.
3. Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996; 93: 10614-10619.
4. Rusan NM, Reifer M. A role for a novel centrosome cycle in asymmetric cell division. J Cell Biol 2007; 177: 13-20.
5. Kubo A, Tsukita S. Non-membranous granular organelle consisting of PCM-1: subcellular distribution and cell-cycle-dependent assembly/ disassembly. J Cell Sci 2003; 116: 919-928.
6. Dammermann A, Merdes A. Assembly of centrosomal proteins and microtubule organization depends on PCM-1. J Cell Biol 2002; 159: 255-266.
7. Li Q, Hansen D, Killilea A, Joshi HC, Palazzo RE, Balczon R. Kendrin/ pericentrin-B, a centrosome protein with homology to pericentrin that complexes with PCM-1. J Cell Sci 2001; 114: 797-809.
8. Gurling HM, Critchley H, Datta SR, McQuillin A, Blaveri E, Thirumalai S, et al. Genetic association and brain morphology studies and the chromosome 8p22 pericentriolar material 1 (PCM1) gene in susceptibility to schizophrenia. Arch Gen Psychiatry 2006; 63: 844-854.
9. Bousquet M, Quelen C, De Mas V, Duchayne E, Roquefeuil B, Delsol G, et al. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene. Oncogene 2005; 24: 7248-7252.
10. Qi C, Zhu Y, Reddy JK. Peroxisome proliferator-activated receptors, coactivators, and downstream targets. Cell Biochem Biophys 2002; 32: 187-204.
11. Scheffer GL, de Jong MC, Monks A, Flens MJ, Hose CD, Izquierdo MA, et al. Increased expression of beta 2-microglobulin in multidrug-resistant tumor cells. Br J Cancer 2002; 86: 1943-1950.
12. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002; 62: 283-289.
13. Liu ZQ, Tian YQ, Hu YF, Li XL, Ma FR, Li GY. Alteration of gene expression during nasopharyngeal carcinogenesis revealed by oligonucleotide microarray after microdissection of tumor tissue and normal epithelia from nasopharynx. Chin Med J 2009; 122: 437-443.
14. Xu QY, Gao Y, Liu Y, Yang WZ, Xu XY. Identification of differential gene expression profiles of radioresistant lung cancer cell line established by fractionated ionizing radiation in vitro. Chin Med J 2008; 121: 1830-1837.
15. Konstantinopoulos PA, Spentzos D, Cannistra SA. Gene-expression profiling in epithelial ovarian cancer. Nat Clin Pract Oncol 2008; 5: 577-587.
16. Gava N, L Clarke C, Bye C, Byth K, deFazio A. Global gene expression profiles of ovarian surface epithelial cell in vivo. J Mol Endocrinol 2008; 14: 2690-2695.
17. Gevaert O, De Smet F, Van Gorp T, Pochet N, Engelen K, Amant F, et al. Expression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluation. BMC Cancer 2008; 8: 18.
18. Xu S, Mou H, Lu G, Zhu C, Yang Z, Gao Y, Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip. Chin Med J 2002; 115: 36-41.
19. Li M, Reilly C. Assessing the quality of hybridized RNA in Affymetrix GeneChips using linear regression. J Biomol Tech 2008; 19: 122-128.
20. Grazio D, Pichler I, Fuchsberger C, Zolezzi F, Guarnieri P, Heidegger H, et al. Differential gene expression analysis of ovarian cancer in a population isolate. Eur J Gynaecol Oncol. 2008; 29: 357-363.